The goal of this educational grand rounds series is to examine recently published and emerging CVOT data for glucose lowering therapies, assess clinical implications of CVOT results on real-world diabetes treatment selection, and explore opportunities for cardiologists to partner with endocrinologists and primary care providers to improve cardiovascular outcomes in patients with diabetes.